About Cyclica
Cyclica is a company based in Toronto (Canada) founded in 2010 was acquired by Recursion in May 2023.. Cyclica has raised $21.06 million across 7 funding rounds from investors including Recursion Pharmaceuticals, Gates Foundation and Chiesi Pharmaceuticals. Cyclica operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Cyrus Biotechnology and Vividion Therapeutics, among others.
- Headquarter Toronto, Canada
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cyclica Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.06 M (USD)
in 7 rounds
-
Latest Funding Round
$1.81 M (USD), Grant
Nov 15, 2022
-
Investors
Recursion Pharmaceuticals
& 9 more
-
Employee Count
Employee Count
-
Acquired by
Recursion
(May 08, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cyclica
Cyclica has successfully raised a total of $21.06M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.81 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $1.8M
-
First Round
First Round
(10 Dec 2013)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Grant - Cyclica | Valuation |
investors |
|
| Apr, 2020 | Amount | Series B - Cyclica | Valuation | Drive Capital | |
| Jul, 2017 | Amount | Series A - Cyclica | Valuation | GreenSky |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cyclica
Cyclica has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Recursion Pharmaceuticals, Gates Foundation and Chiesi Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on pre-seed and seed stage investments
|
Founded Year | Domain | Location | |
|
Early stage Canadian B2B startups are funded by GreenSky Ventures.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cyclica
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cyclica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cyclica Comparisons
Competitors of Cyclica
Cyclica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Cyrus Biotechnology and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cyclica
Frequently Asked Questions about Cyclica
When was Cyclica founded?
Cyclica was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Cyclica located?
Cyclica is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Is Cyclica a funded company?
Cyclica is a funded company, having raised a total of $21.06M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2.25M, raised on Dec 10, 2013.
What does Cyclica do?
Online AI-interface predictive analytics platform for drug discovery and testing. It is a biotechnology company that offers a biomolecular analytics platform for proteome docking. It uses proprietary algorithms and databases to improve drug discovery pipelines by identifying risks such as adverse effects, contraindications, and lack of efficacy. It uses multi-channel systems for evaluating and comparing small molecules to predict the reaction with the human body and searches for all proteins that have potential drug-protein interactions. It also offers a proprietary database of bacterial and viral proteomes that can be used to identify new treatments for infectious diseases.
Who are the top competitors of Cyclica?
Cyclica's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Who are Cyclica's investors?
Cyclica has 10 investors. Key investors include Recursion Pharmaceuticals, Gates Foundation, Chiesi Pharmaceuticals, StartUp Health, and Drive Capital.